Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Michael Graner

Concepts (418)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Extracellular Vesicles
9
2024
148
3.700
Why?
Exosomes
11
2020
105
2.690
Why?
Glioma
10
2019
403
2.440
Why?
Cancer Vaccines
17
2018
166
1.960
Why?
Molecular Chaperones
17
2013
193
1.840
Why?
Brain Neoplasms
12
2022
1268
1.700
Why?
Tumor Microenvironment
5
2024
668
1.680
Why?
Brain Ischemia
2
2025
343
1.330
Why?
Neoplasms
11
2021
2701
1.310
Why?
Multiple Sclerosis
8
2023
460
1.270
Why?
Cytokines
7
2024
2084
1.050
Why?
Antigens, Neoplasm
7
2018
317
0.960
Why?
Glioblastoma
4
2022
341
0.940
Why?
Unfolded Protein Response
3
2016
59
0.940
Why?
Interleukin-6
5
2025
786
0.940
Why?
Immunoglobulin G
7
2023
903
0.930
Why?
HSP90 Heat-Shock Proteins
4
2015
46
0.930
Why?
Proteome
6
2024
471
0.920
Why?
Chordoma
1
2024
14
0.890
Why?
Immune Tolerance
2
2018
366
0.880
Why?
Cell Movement
7
2024
972
0.870
Why?
Oligoclonal Bands
4
2022
20
0.870
Why?
HSP70 Heat-Shock Proteins
7
2015
74
0.860
Why?
Osteoblasts
1
2024
131
0.850
Why?
Heat-Shock Proteins
8
2013
143
0.830
Why?
Stroke
2
2023
1137
0.810
Why?
Gene Expression Regulation, Neoplastic
7
2024
1388
0.790
Why?
Epithelial-Mesenchymal Transition
1
2024
211
0.780
Why?
Ischemic Attack, Transient
1
2023
67
0.750
Why?
Cell Line, Tumor
19
2024
3406
0.690
Why?
Extracellular Space
4
2015
125
0.690
Why?
Proteomics
6
2024
1113
0.690
Why?
Immunity
4
2018
141
0.680
Why?
Meningioma
1
2022
94
0.680
Why?
Antineoplastic Agents
7
2021
2161
0.670
Why?
Meningeal Neoplasms
1
2022
102
0.670
Why?
Astrocytes
2
2019
215
0.610
Why?
Vacuolar Proton-Translocating ATPases
1
2019
15
0.610
Why?
Antigen Presentation
4
2018
219
0.600
Why?
Immunomodulation
2
2018
99
0.580
Why?
Neoplasm Proteins
2
2016
433
0.580
Why?
RNA, Neoplasm
1
2018
79
0.570
Why?
MicroRNAs
3
2018
680
0.530
Why?
T-Lymphocytes
4
2018
1983
0.510
Why?
Brain Injuries
1
2021
496
0.490
Why?
Calreticulin
2
2013
28
0.450
Why?
Signal Transduction
8
2020
5091
0.450
Why?
Cell Proliferation
7
2018
2473
0.440
Why?
Humans
59
2025
138631
0.430
Why?
Animals
42
2023
37302
0.420
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2013
19
0.410
Why?
Mice, Inbred BALB C
15
2014
1261
0.400
Why?
Leukocytes, Mononuclear
1
2015
570
0.380
Why?
Dog Diseases
1
2013
65
0.380
Why?
Autoantibodies
1
2020
1454
0.380
Why?
Heat-Shock Response
2
2015
75
0.370
Why?
Cerebellar Neoplasms
1
2012
153
0.330
Why?
Medulloblastoma
1
2012
193
0.330
Why?
Stress, Physiological
1
2013
454
0.320
Why?
Dendritic Cells
12
2008
492
0.310
Why?
Mice
26
2023
17841
0.310
Why?
Transcription Factors
2
2014
1707
0.310
Why?
Mycobacterium tuberculosis
7
2015
317
0.300
Why?
Drug Resistance, Neoplasm
2
2013
800
0.290
Why?
Tuberculosis
4
2015
280
0.290
Why?
Carrier Proteins
2
2009
739
0.270
Why?
Transforming Growth Factor beta
4
2024
487
0.260
Why?
Peptides
5
2024
984
0.260
Why?
Isoelectric Focusing
3
2015
31
0.250
Why?
Neoplasms, Experimental
3
2006
174
0.250
Why?
Lymphocyte Activation
5
2012
1145
0.250
Why?
Histocompatibility Antigens Class I
3
2018
203
0.250
Why?
Interferon-gamma
8
2015
789
0.240
Why?
Immunotherapy
3
2021
631
0.230
Why?
Case-Control Studies
5
2021
3580
0.230
Why?
Oligopeptides
4
2007
272
0.230
Why?
Female
30
2025
73891
0.230
Why?
Tetraspanin 28
1
2024
6
0.220
Why?
alpha-Synuclein
1
2024
41
0.220
Why?
Amino Acid Sequence
6
2020
2162
0.220
Why?
Fusion Proteins, bcr-abl
4
2007
70
0.210
Why?
Albumins
1
2004
116
0.210
Why?
Middle Aged
14
2025
33788
0.210
Why?
Apoptosis
5
2023
2558
0.210
Why?
Integrins
3
1998
95
0.210
Why?
Leukemia, B-Cell
2
2000
13
0.210
Why?
Multiple Sclerosis, Chronic Progressive
1
2023
28
0.200
Why?
Sensitivity and Specificity
3
2025
1958
0.200
Why?
Neuroblastoma
2
2023
160
0.190
Why?
Multiple Sclerosis, Relapsing-Remitting
1
2023
76
0.190
Why?
Aged, 80 and over
3
2025
7683
0.190
Why?
Drosophila Proteins
3
1998
202
0.190
Why?
Tuberculosis, Pleural
2
2014
6
0.190
Why?
Transferases
1
2022
33
0.190
Why?
Membrane Glycoproteins
4
2015
500
0.190
Why?
Tuberculosis, Pulmonary
3
2012
142
0.180
Why?
Lung Neoplasms
2
2013
2531
0.180
Why?
Organ Specificity
2
2020
310
0.180
Why?
Male
19
2025
68214
0.180
Why?
Leukemia
4
2006
241
0.180
Why?
Melanoma
2
2024
766
0.180
Why?
Peptide Fragments
4
2020
691
0.170
Why?
Epitopes
2
2020
476
0.170
Why?
Blotting, Western
4
2009
1229
0.170
Why?
Tissue Plasminogen Activator
1
2023
231
0.170
Why?
Xenograft Model Antitumor Assays
4
2013
865
0.170
Why?
Cell Extracts
3
2006
21
0.170
Why?
Biomarkers
5
2025
4111
0.170
Why?
Ultracentrifugation
1
2020
52
0.170
Why?
Laser Capture Microdissection
1
2020
32
0.170
Why?
Extracellular Matrix Proteins
2
1998
155
0.160
Why?
Plasma Cells
1
2020
73
0.160
Why?
Tumor Cells, Cultured
7
2007
949
0.160
Why?
Aged
7
2025
24181
0.160
Why?
CD4-Positive T-Lymphocytes
3
2012
1101
0.160
Why?
Antibody Specificity
1
2020
187
0.160
Why?
Peptide Library
1
2020
95
0.160
Why?
Protein Transport
2
2019
441
0.160
Why?
Immunosuppressive Agents
1
2004
867
0.160
Why?
Virus Latency
1
2020
79
0.160
Why?
T-Lymphocytes, Cytotoxic
8
2015
174
0.150
Why?
Prognosis
2
2021
4015
0.150
Why?
Cells, Cultured
6
2015
4174
0.150
Why?
Epstein-Barr Virus Infections
1
2020
98
0.150
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
2007
125
0.150
Why?
Bacteriophages
1
2020
99
0.150
Why?
Receptors, Purinergic
1
2018
19
0.150
Why?
Lymphoma, B-Cell
1
2000
127
0.150
Why?
Tenascin
1
1998
15
0.150
Why?
Transcription, Genetic
3
2014
1462
0.140
Why?
Laminin
1
1998
71
0.140
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2017
981
0.140
Why?
Receptors, Fc
1
2018
55
0.140
Why?
Antigen-Presenting Cells
1
2018
157
0.140
Why?
Milk
1
2018
123
0.140
Why?
Alzheimer Disease
1
2024
570
0.140
Why?
DNA, Viral
1
2020
369
0.140
Why?
Alternative Splicing
2
2006
227
0.140
Why?
Drug Carriers
1
2018
126
0.140
Why?
Immune System
1
2019
181
0.140
Why?
Cell Hypoxia
2
2015
231
0.130
Why?
Nanoparticles
2
2020
468
0.130
Why?
Biological Transport
1
2018
403
0.130
Why?
Autoantigens
1
2020
423
0.130
Why?
Ovarian Neoplasms
2
2017
575
0.130
Why?
Prostatic Neoplasms
2
2015
1048
0.130
Why?
Time Factors
2
2025
6877
0.130
Why?
DNA Methylation
1
2022
637
0.130
Why?
Antigens, Bacterial
2
2015
125
0.130
Why?
Host-Pathogen Interactions
1
2020
375
0.130
Why?
Herpesvirus 3, Human
1
2020
331
0.130
Why?
Inflammation
2
2019
2856
0.120
Why?
Adenosine Triphosphate
1
2018
489
0.120
Why?
Mass Spectrometry
2
2016
741
0.120
Why?
Protein Array Analysis
1
2015
56
0.120
Why?
Antigens, Surface
1
2015
153
0.120
Why?
Lymphocytes
1
2017
399
0.120
Why?
DNA
1
2022
1449
0.110
Why?
Brain
3
2020
2782
0.110
Why?
Sequence Analysis, RNA
1
2017
452
0.110
Why?
Neurons
2
2022
1603
0.110
Why?
Alkynes
1
2014
57
0.110
Why?
Granuloma
1
2015
97
0.110
Why?
Azides
1
2014
47
0.110
Why?
RNA, Messenger
5
2020
2816
0.110
Why?
Acute Lung Injury
1
2017
299
0.110
Why?
Click Chemistry
1
2014
50
0.110
Why?
Lung
3
2017
4086
0.110
Why?
BCG Vaccine
2
2010
25
0.110
Why?
Adherens Junctions
1
2013
25
0.110
Why?
Interferon-gamma Release Tests
1
2014
32
0.100
Why?
Basigin
1
2013
25
0.100
Why?
Intestinal Mucosa
1
2018
621
0.100
Why?
Pleural Effusion
1
2014
56
0.100
Why?
Flow Cytometry
3
2012
1197
0.100
Why?
Antineoplastic Agents, Alkylating
1
2013
69
0.100
Why?
Adult
13
2024
38291
0.100
Why?
Dacarbazine
1
2013
97
0.100
Why?
Histocompatibility Antigens Class II
2
2013
365
0.100
Why?
Lipogenesis
1
2013
61
0.100
Why?
Triglycerides
1
2015
515
0.100
Why?
Matrix Metalloproteinase 9
1
2013
131
0.100
Why?
Drosophila
3
1998
154
0.100
Why?
Endoplasmic Reticulum Stress
1
2013
117
0.100
Why?
Hepatocyte Nuclear Factor 4
1
2012
14
0.100
Why?
ErbB Receptors
2
2006
613
0.100
Why?
Prostate
1
2013
174
0.100
Why?
Transforming Growth Factor beta1
1
2013
165
0.100
Why?
Neoplasm Grading
1
2013
306
0.090
Why?
Mice, Inbred C57BL
6
2017
5807
0.090
Why?
Tumor Burden
1
2013
307
0.090
Why?
Dogs
1
2013
426
0.090
Why?
Liver
2
2013
1876
0.090
Why?
B-Lymphocytes
2
2022
856
0.090
Why?
Neutrophils
1
2017
1279
0.090
Why?
B-Lymphocyte Subsets
1
2012
77
0.090
Why?
Treatment Outcome
3
2023
10938
0.090
Why?
Cell Line
4
2020
2874
0.090
Why?
Epithelial Cells
1
2017
1102
0.090
Why?
Mice, Nude
3
2007
689
0.090
Why?
Cell Survival
2
2012
1129
0.090
Why?
Gene Regulatory Networks
1
2013
310
0.090
Why?
Phenotype
3
2018
3160
0.090
Why?
Enzyme-Linked Immunospot Assay
1
2010
37
0.090
Why?
Th17 Cells
1
2012
108
0.090
Why?
Radiography
1
2013
846
0.080
Why?
RNA-Binding Proteins
1
2014
428
0.080
Why?
Interleukin-17
1
2011
120
0.080
Why?
Oxygen
1
2015
967
0.080
Why?
Latent Tuberculosis
1
2010
68
0.080
Why?
Receptors, Interleukin-6
1
2009
46
0.080
Why?
Immunohistochemistry
3
2009
1731
0.080
Why?
Immunity, Innate
1
2015
828
0.080
Why?
Tissue Array Analysis
1
2009
51
0.080
Why?
Interleukins
1
2011
251
0.080
Why?
Mycobacterium bovis
1
2009
17
0.080
Why?
Receptors, Vascular Endothelial Growth Factor
2
2008
108
0.080
Why?
T-Lymphocytes, Helper-Inducer
1
2009
137
0.080
Why?
Cross-Priming
1
2008
16
0.080
Why?
Electrophoresis, Gel, Two-Dimensional
1
2008
112
0.070
Why?
Enzyme-Linked Immunosorbent Assay
3
2023
856
0.070
Why?
Antigens, Differentiation
1
2008
81
0.070
Why?
Toll-Like Receptor 2
1
2009
116
0.070
Why?
Adaptor Proteins, Signal Transducing
2
2009
430
0.070
Why?
Carcinoma, Lewis Lung
2
2005
15
0.070
Why?
Neoplasm Transplantation
3
2006
251
0.070
Why?
Blood-Brain Barrier
1
2008
140
0.070
Why?
Immunization
3
2015
405
0.070
Why?
Immunotherapy, Active
1
2007
9
0.070
Why?
Tissue Extracts
1
2007
21
0.070
Why?
DNA-Binding Proteins
1
2014
1476
0.070
Why?
Hypoxia
1
2013
1137
0.060
Why?
Angiogenesis Inhibitors
1
2008
230
0.060
Why?
Tissue Distribution
2
2018
333
0.060
Why?
Cell Membrane
1
2009
715
0.060
Why?
Vitamin E
1
2005
123
0.060
Why?
T-Lymphocyte Subsets
1
2007
417
0.060
Why?
Integrin alpha Chains
3
1998
24
0.050
Why?
Spleen
2
2004
523
0.050
Why?
Amyloidogenic Proteins
1
2024
16
0.050
Why?
Quinazolines
1
2005
250
0.050
Why?
Piperidines
1
2005
215
0.050
Why?
Molecular Sequence Data
3
2015
2928
0.050
Why?
Central Nervous System Neoplasms
1
2005
165
0.050
Why?
Kinetics
2
2006
1654
0.050
Why?
Neoplasm Invasiveness
2
2015
501
0.050
Why?
Disease Models, Animal
1
2013
4333
0.050
Why?
Immunotherapy, Adoptive
2
2004
350
0.050
Why?
Plasma
1
2024
221
0.050
Why?
Interleukin-12
3
2008
123
0.050
Why?
Piperazines
1
2004
349
0.050
Why?
Recombinant Proteins
2
2020
1357
0.040
Why?
Survival Analysis
2
2006
1313
0.040
Why?
Hyperthermia, Induced
1
2002
121
0.040
Why?
Head and Neck Neoplasms
1
2006
554
0.040
Why?
Carcinoma, Squamous Cell
1
2006
646
0.040
Why?
Cell Division
1
2003
791
0.040
Why?
Chromatography
1
2000
23
0.040
Why?
Epstein-Barr Virus Nuclear Antigens
1
2020
12
0.040
Why?
Chemical Precipitation
1
2020
38
0.040
Why?
Pyrimidines
1
2004
476
0.040
Why?
Dose-Response Relationship, Drug
2
2005
2045
0.040
Why?
Lymphocyte Culture Test, Mixed
3
2007
51
0.040
Why?
Injections, Spinal
1
2020
108
0.040
Why?
Electrophoresis, Polyacrylamide Gel
1
2000
339
0.040
Why?
bcl-X Protein
1
2020
43
0.040
Why?
Immediate-Early Proteins
1
2020
49
0.040
Why?
Lipids
1
2004
674
0.040
Why?
Hematopoietic Stem Cell Transplantation
1
2006
661
0.040
Why?
Electron Transport Complex IV
1
2020
60
0.040
Why?
Complement System Proteins
1
2023
321
0.040
Why?
3T3 Cells
1
2000
164
0.040
Why?
Vaccination
1
2008
1435
0.040
Why?
Herpesvirus 4, Human
1
2020
165
0.040
Why?
Ligands
2
1998
665
0.040
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2000
151
0.040
Why?
Viral Envelope Proteins
1
2020
97
0.040
Why?
China
2
2010
213
0.040
Why?
Up-Regulation
2
2013
851
0.040
Why?
Caspase 3
1
2020
250
0.040
Why?
Carbocyanines
1
2018
33
0.040
Why?
Ribonucleoproteins
1
2000
104
0.040
Why?
Proto-Oncogene Proteins c-bcl-2
1
2020
238
0.040
Why?
Calcium-Binding Proteins
1
2000
214
0.040
Why?
Biological Availability
1
2018
138
0.040
Why?
Permeability
1
2018
161
0.040
Why?
Protein Conformation
2
1998
944
0.040
Why?
Solubility
1
2018
241
0.040
Why?
RNA Transport
1
2017
23
0.030
Why?
Young Adult
5
2014
13321
0.030
Why?
Poly(ADP-ribose) Polymerases
1
2017
98
0.030
Why?
Th1 Cells
2
2012
142
0.030
Why?
Fluorescent Dyes
1
2018
320
0.030
Why?
Cell Adhesion
1
1998
465
0.030
Why?
Gene Knockdown Techniques
1
2017
329
0.030
Why?
Administration, Oral
1
2018
789
0.030
Why?
Gene Expression Regulation
2
2020
2602
0.030
Why?
Antibodies, Viral
1
2020
649
0.030
Why?
Cattle
1
2018
996
0.030
Why?
Drug Screening Assays, Antitumor
2
2007
193
0.030
Why?
Cell Communication
1
2017
316
0.030
Why?
Blood Proteins
1
2017
248
0.030
Why?
Antibodies, Monoclonal
3
2008
1437
0.030
Why?
Fetus
1
2020
801
0.030
Why?
Pharmaceutical Vehicles
1
2014
12
0.030
Why?
Muscle Contraction
1
1998
435
0.030
Why?
HSP72 Heat-Shock Proteins
2
2007
32
0.030
Why?
Fibroblasts
1
2020
1001
0.030
Why?
Cycloaddition Reaction
1
2014
28
0.030
Why?
Chemistry, Pharmaceutical
1
2014
104
0.030
Why?
Injections, Intravenous
1
2014
204
0.030
Why?
Fluorescence
1
2015
159
0.030
Why?
Protein Binding
1
2000
2236
0.030
Why?
Antibiotics, Antineoplastic
1
2014
124
0.030
Why?
Tetraspanins
1
2013
19
0.030
Why?
Annexin A2
1
2013
16
0.030
Why?
Phosphatidylcholines
1
2014
136
0.030
Why?
Copper
1
2014
110
0.030
Why?
Metalloproteases
1
2013
42
0.030
Why?
Choline
1
2014
131
0.030
Why?
Epitopes, T-Lymphocyte
1
2015
184
0.030
Why?
Cross-Linking Reagents
1
2014
215
0.030
Why?
Membrane Proteins
1
2000
1153
0.030
Why?
Bone Marrow Cells
2
2007
325
0.030
Why?
Particle Size
1
2014
391
0.030
Why?
Surface Properties
1
2014
411
0.030
Why?
Feedback, Physiological
1
2013
81
0.030
Why?
Coculture Techniques
1
2013
241
0.020
Why?
Liposomes
1
2014
218
0.020
Why?
Doxorubicin
1
2014
351
0.020
Why?
CD5 Antigens
1
2012
9
0.020
Why?
Ionomycin
1
2012
22
0.020
Why?
Antigens, CD1d
1
2012
68
0.020
Why?
Tetradecanoylphorbol Acetate
1
2012
156
0.020
Why?
Lymphocyte Count
1
2012
167
0.020
Why?
Cell Aggregation
1
2011
26
0.020
Why?
Pneumonia
1
2017
643
0.020
Why?
Drug Delivery Systems
1
2014
359
0.020
Why?
Infant, Newborn
1
2023
6143
0.020
Why?
Antigens, CD19
1
2012
130
0.020
Why?
Phosphorylation
2
2005
1770
0.020
Why?
Interleukin-2
1
2012
451
0.020
Why?
Prospective Studies
2
2014
7639
0.020
Why?
Monophenol Monooxygenase
1
2008
8
0.020
Why?
Immunoenzyme Techniques
1
2009
209
0.020
Why?
Radioimmunotherapy
1
2008
21
0.020
Why?
Genes, Insect
2
1998
22
0.020
Why?
Predictive Value of Tests
1
2014
2039
0.020
Why?
Interleukin-8
1
2009
271
0.020
Why?
Vaccines, DNA
1
2008
32
0.020
Why?
Vascular Endothelial Growth Factors
1
2008
80
0.020
Why?
Immunization, Passive
1
2008
92
0.020
Why?
Vaccines, Subunit
1
2008
50
0.020
Why?
Wings, Animal
2
1998
35
0.020
Why?
Immunotoxins
1
2008
56
0.020
Why?
Adolescent
3
2012
21528
0.020
Why?
Calbindin 2
1
2007
8
0.020
Why?
Down-Regulation
1
2009
638
0.020
Why?
S100 Calcium Binding Protein G
1
2007
8
0.020
Why?
Egg Proteins
1
2007
17
0.020
Why?
HLA-A2 Antigen
1
2007
49
0.020
Why?
Animals, Genetically Modified
2
1998
243
0.020
Why?
Ovalbumin
1
2007
190
0.020
Why?
Tumor Necrosis Factor-alpha
1
2012
1248
0.020
Why?
Cytotoxicity, Immunologic
1
2007
225
0.020
Why?
Biomarkers, Tumor
1
2013
1236
0.020
Why?
Transplantation, Isogeneic
1
2006
16
0.020
Why?
Antigen-Antibody Reactions
1
2006
55
0.020
Why?
Transplantation, Heterologous
1
2006
194
0.020
Why?
Drug Synergism
1
2007
371
0.020
Why?
Mutation
3
2006
3998
0.020
Why?
Hot Temperature
1
2008
394
0.020
Why?
Dosage Forms
1
2005
9
0.010
Why?
Tocopherols
1
2005
26
0.010
Why?
Ki-67 Antigen
1
2005
110
0.010
Why?
alpha-Macroglobulins
1
2005
24
0.010
Why?
Ultrasonics
1
2005
50
0.010
Why?
T-Lymphocytes, Regulatory
1
2008
388
0.010
Why?
Mitogen-Activated Protein Kinase 3
1
2005
149
0.010
Why?
Lymphocytes, Tumor-Infiltrating
1
2007
206
0.010
Why?
Mitogen-Activated Protein Kinase 1
1
2005
183
0.010
Why?
T-Cell Antigen Receptor Specificity
1
2004
51
0.010
Why?
HeLa Cells
1
2006
639
0.010
Why?
Imatinib Mesylate
1
2004
80
0.010
Why?
Neovascularization, Pathologic
1
2005
296
0.010
Why?
Ependymoma
1
2005
163
0.010
Why?
In Vitro Techniques
1
2005
1093
0.010
Why?
Benzamides
1
2004
213
0.010
Why?
Cell-Free System
1
2003
55
0.010
Why?
Chaperonin 60
1
2002
13
0.010
Why?
CD40 Antigens
1
2003
89
0.010
Why?
Protein Folding
1
2003
279
0.010
Why?
Drug Evaluation, Preclinical
1
2002
193
0.010
Why?
Severity of Illness Index
1
2009
2861
0.010
Why?
Tomography, X-Ray Computed
1
2012
2703
0.010
Why?
Combined Modality Therapy
1
2004
1237
0.010
Why?
Adjuvants, Immunologic
1
2002
237
0.010
Why?
CD8-Positive T-Lymphocytes
1
2007
912
0.010
Why?
Immunity, Cellular
1
2002
270
0.010
Why?
Gene Expression Profiling
1
2006
1755
0.010
Why?
Cell Differentiation
1
2007
2000
0.010
Why?
Pupa
1
1998
12
0.010
Why?
Genes, Lethal
1
1998
30
0.010
Why?
Recombinant Fusion Proteins
1
2001
662
0.010
Why?
Crosses, Genetic
1
1998
135
0.010
Why?
DNA, Complementary
1
1998
276
0.010
Why?
Abdomen
1
1998
132
0.010
Why?
Sequence Homology, Amino Acid
1
1998
393
0.010
Why?
Larva
1
1998
235
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2006
1748
0.010
Why?
Cytoplasm
1
1998
270
0.010
Why?
Muscles
1
1998
332
0.010
Why?
HIV Infections
1
2010
2944
0.010
Why?
Retina
1
1998
303
0.010
Why?
Base Sequence
1
1998
2182
0.010
Why?
Gene Expression Regulation, Developmental
1
1998
875
0.010
Why?
Risk Factors
1
2006
10395
0.010
Why?
Retrospective Studies
1
2006
15859
0.000
Why?
Graner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)